1
|
Tanner V, Faiss R, Saugy J, Bourdillon N, Schmitt L, Millet GP. Similar Supine Heart Rate Variability Changes During 24-h Exposure to Normobaric vs. Hypobaric Hypoxia. Front Neurosci 2021; 15:777800. [PMID: 34955728 PMCID: PMC8695977 DOI: 10.3389/fnins.2021.777800] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2021] [Accepted: 11/22/2021] [Indexed: 01/22/2023] Open
Abstract
Purpose: This study aimed to investigate the differences between normobaric (NH) and hypobaric hypoxia (HH) on supine heart rate variability (HRV) during a 24-h exposure. We hypothesized a greater decrease in parasympathetic-related parameters in HH than in NH. Methods: A pooling of original data from forty-one healthy lowland trained men was analyzed. They were exposed to altitude either in NH (FIO2 = 15.7 ± 2.0%; PB = 698 ± 25 mmHg) or HH (FIO2 = 20.9%; PB = 534 ± 42 mmHg) in a randomized order. Pulse oximeter oxygen saturation (SpO2), heart rate (HR), and supine HRV were measured during a 7-min rest period three times: before (in normobaric normoxia, NN), after 12 (H12), and 24 h (H24) of either NH or HH exposure. HRV parameters were analyzed for time- and frequency-domains. Results: SpO2 was lower in both hypoxic conditions than in NN and was higher in NH than HH at H24. Subjects showed similarly higher HR during both hypoxic conditions than in NN. No difference in HRV parameters was found between NH and HH at any time. The natural logarithm of root mean square of the successive differences (LnRMSSD) and the high frequency spectral power (HF), which reflect parasympathetic activity, decreased similarly in NH and HH when compared to NN. Conclusion: Despite SpO2 differences, changes in supine HRV parameters during 24-h exposure were similar between NH and HH conditions indicating a similar decrease in parasympathetic activity. Therefore, HRV can be analyzed similarly in NH and HH conditions.
Collapse
Affiliation(s)
- Valérian Tanner
- Medicine School, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland
| | - Raphael Faiss
- Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland.,REDs, Research and Expertise in Anti-Doping Sciences, University of Lausanne, Lausanne, Switzerland
| | - Jonas Saugy
- Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland.,REDs, Research and Expertise in Anti-Doping Sciences, University of Lausanne, Lausanne, Switzerland
| | - Nicolas Bourdillon
- Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland
| | - Laurent Schmitt
- National Centre of Nordic-Ski, Research and Performance, Prémanon, France
| | - Grégoire P Millet
- Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland
| |
Collapse
|
2
|
DiMarco KG, Beasley KM, Shah K, Speros JP, Elliott JE, Laurie SS, Duke JW, Goodman RD, Futral JE, Hawn JA, Roach RC, Lovering AT. No effect of patent foramen ovale on acute mountain sickness and pulmonary pressure in normobaric hypoxia. Exp Physiol 2021; 107:122-132. [PMID: 34907608 DOI: 10.1113/ep089948] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2021] [Accepted: 12/08/2021] [Indexed: 11/08/2022]
Abstract
What is the central question to this study? Is there a relationship between a patent foramen ovale and the development of acute mountain sickness and an exaggerated increase in pulmonary pressure in response to 7-10 hours of normobaric hypoxia? What is the main finding and its importance? Patent foramen ovale presence did not increase susceptibility to acute mountain sickness or result in an exaggerated increase in pulmonary artery systolic pressure with normobaric hypoxia. This data suggest hypobaric hypoxia is integral to the increased susceptibility to acute mountain sickness previously reported in those with patent foramen ovale, and patent foramen ovale presence alone does not contribute to the hypoxic pulmonary pressor response. ABSTRACT: Acute mountain sickness (AMS) develops following rapid ascent to altitude, but its exact causes remain unknown. A patent foramen ovale (PFO) is a right-to-left intracardiac shunt present in ∼30% of the population that has been shown to increase AMS susceptibility with high altitude hypoxia. Additionally, high altitude pulmonary edema (HAPE), is a severe type of altitude illness characterized by an exaggerated pulmonary pressure response, and there is a greater prevalence of PFO in those with a history of HAPE. However, whether hypoxia, per se, is causing the increased incidence of AMS in those with a PFO and whether a PFO is associated with an exaggerated increase in pulmonary pressure in those without a history of HAPE is unknown. Participants (n = 36) matched for biological sex (18 female) and the presence or absence of a PFO (18 PFO+) were exposed to 7-10 hours of normobaric hypoxia equivalent to 4755 m. Presence and severity of AMS was determined using the Lake Louise AMS scoring system. Pulmonary artery systolic pressure, cardiac output, and total pulmonary resistance were measured using ultrasound. We found no significant association of PFO with incidence or severity of AMS and no association of PFO with arterial oxygen saturation. Additionally, there was no effect of a PFO on pulmonary pressure, cardiac output, or total pulmonary resistance. These data suggest that hypobaric hypoxia is necessary for those with a PFO to have increased incidence of AMS and that presence of PFO is not associated with an exaggerated pulmonary pressor response. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Kaitlyn G DiMarco
- University of Oregon, Department of Human Physiology, Eugene, OR, USA
| | - Kara M Beasley
- University of Oregon, Department of Human Physiology, Eugene, OR, USA
| | - Karina Shah
- University of Oregon, Department of Human Physiology, Eugene, OR, USA
| | - Julia P Speros
- University of Oregon, Department of Human Physiology, Eugene, OR, USA
| | - Jonathan E Elliott
- VA Portland Health Care System, Portland, OR, USA.,Oregon Health and Science University, Department of Neurology, Portland, OR, USA
| | - Steven S Laurie
- KBR, Cardiovascular and Vision Laboratory, NASA Johnson Space Center, Houston, TX, USA
| | - Joseph W Duke
- Northern Arizona University, Department of Biological Sciences, Flagstaff, AZ, USA
| | | | | | - Jerold A Hawn
- Oregon Heart and Vascular Institute, Springfield, OR, USA
| | - Robert C Roach
- University of Colorado Anschutz Medical Campus, Altitude Research Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Aurora, CO, USA
| | - Andrew T Lovering
- University of Oregon, Department of Human Physiology, Eugene, OR, USA
| |
Collapse
|